Skip to main content
Download PDF
  • Retraction Note
  • Open access
  • Published:

Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway

Stem Cell Research & Therapy volume 12, Article number: 529 (2021) Cite this article

The Original Article was published on 05 February 2021

Retraction Note to: Stem Cell Research & Therapy (2021) 12:115 https://doi.org/10.1186/s13287-021-02183-2

The authors have retracted this article. After publication the authors became aware of issues with two of the figures, specifically:

  • In Fig. 5c the echocardiography images for 1 week and 3 weeks for the MI + HG group had been duplicated owing to an error in the assembly of the figure.

  • In Fig. 3a the bands for Beclin 1 had been constructed by using the bands from P21 in Fig. 2e during assembly of the figure.

All authors agree with this retraction.

Author information

Authors and Affiliations

  1. Department of Cardiology, the Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221000, People’s Republic of China

    Fengyun Zhang & Zhuoqi Zhang

  2. Department of Cardiology, Institute of Cardiovascular Research, Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China

    Fei Gao & Xiaohong Liu

  3. Department of Cardiology, First People’s Hospital of Suqian, Suqian, People’s Republic of China

    Kun Wang

Authors
  1. Fengyun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fei Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaohong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhuoqi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhuoqi Zhang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, F., Gao, F., Wang, K. et al. Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway. Stem Cell Res Ther 12, 529 (2021). https://doi.org/10.1186/s13287-021-02606-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13287-021-02606-0

Stem Cell Research & Therapy

ISSN: 1757-6512